Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Blackford Analysis introduces SDK for medical image comparison acceleration at HIMSS 2014

    Feb 24, 2014, 00:00 AM by Michael Croft
    EDINBURGH, UK - Feb 24, 2014 - Blackford Analysis, a provider of software products that accelerate comparison of medical images, today announced it will introduce its software development kit (SDK) to enable medical imaging OEMs to enhance their products at the HIMSS Annual Conference and Exhibition in Orlando, Florida
    Full story
  • At HIMSS ’14, Orchard Software Introduces Its Newest Product—Orchard® Sequoia™—An Enterprise-class LIS

    Feb 24, 2014, 00:00 AM by Michael Croft
    CARMEL, IN - Orchard Software - Come see the biggest tree in the Orchard at HIMSS ’14 booth #2283.  At HIMSS ’14 booth #2283, Orchard will showcase its newest lab system product designed for the enterprise-wide laboratory.
    Full story
  • Certara Conducts Model-based Meta-analysis to Compare the Efficacy and Tolerability of Two Chronic Nonmalignant Pain Medications

    Feb 24, 2014, 00:00 AM by Michael Croft
    ST. LOUIS, MO - Feb 24, 2014 - Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced today that its model-based meta-analysis comparing tramadol with tapentadol for the treatment of chronic nonmalignant pain has been published in the journal Pain and Therapy
    Full story
  • LabAnswer Selects John F. Conway as Director of R & D Strategy

    Feb 24, 2014, 00:00 AM by Michael Croft
    SUGAR LAND, TX - LabAnswer, one of the nation’s leading laboratory informatics consultancies, announces the formation of a new position, Director of R & D Strategy and names John  Conway to the position
    Full story
  • Research Across America

    Feb 24, 2014, 00:00 AM by Michael Croft
    READING, PA - Feb 24, 2014 - ~~Research Across America (RAA) is a wholly owned network of clinical investigative sites that conduct clinical trials for prescription and OTC medications and devices
    Full story
  • BGI Plans IPO for BGI Tech

    Feb 21, 2014, 14:00 PM by Michael Croft
    Bloomberg News | BGI Tech, part of BGI, is planning a $400 initial public offering. The IPO will take place in Hong Kong.
    Full story
  • Exostar’s Life Sciences Cloud Collaboration Platform Exceeds Growth Objectives

    Feb 20, 2014, 00:00 AM by Michael Croft
    HERNDON, VA - Feb 20, 0014 - Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, today announced significant milestones in the adoption of its community cloud access and collaboration service offering for the Life Sciences industry
    Full story
  • eClipse CRO to exhibit and speak at Partnerships in Clinical Trials 2014 Las Vegas

    Feb 20, 2014, 00:00 AM by Michael Croft
    EXETER, NH - eClipse CRO to exhibit and speak at Partnerships in Clinical Trials 2014 Las Vegas Exeter, NV
    Full story
  • Bold Claims as GenapSys Opens Early Access to GENIUS

    Feb 19, 2014, 11:10 AM by Michael Croft
    Bio-IT World News Brief | Last week at AGBT 2014, GenapSys opened an early access program for researchers to test out the company's GENIUS sequencer, an instrument the size of a tablet that the company claims will be highly competitive on both speed and cost.
    Full story
  • Novel Encryption Scheme Aims to Secure Genetic Data

    Feb 19, 2014, 09:15 AM by Michael Croft
    ScienceNow | Kristin Lauter of Microsoft has demonstrated a new security scheme for genetic data that allows the data to be mined for information while still encrypted.
    Full story
  • Chas Bountra, Ph.D., to Give Keynote Presentation at CHI’s Structure-Based Drug Design Conference

    Feb 19, 2014, 00:00 AM by Michael Croft
    NEEDHAM, MA - Feb 19, 2014 - Cambridge Healthtech Institute (CHI) today announced Chas Bountra, Ph.D., Chief Scientist & Head of the Structural Genomics Consortium/University of Oxford, will give the keynote presentation at its 14th AnnualStructure-Based Drug Design conference scheduled for May 21-22, 2014 at the Westin Boston Waterfront, Boston, MA
    Full story
  • Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office

    Feb 19, 2014, 00:00 AM by Michael Croft
    ROCKVILLE, MD, US - Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park (RTP), North Carolina
    Full story
  • iRODS Consortium welcomes UK’s Sanger Institute as newest member

    Feb 19, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Feb 19, 2014 - The iRODS Consortium today announced the Wellcome Trust Sanger Institute, a leading institution in the Human Genome Project now focused on understanding the role of genetics in health and disease, as its newest member
    Full story
  • Ayasdi Continues Industry Accolades, Receives Four Major Innovation Awards

    Feb 19, 2014, 00:00 AM by Michael Croft
    PALO ALTO, CA  - Ayasdi (www.ayasdi.com) today announced that it has received four more major industry awards, bringing its total to nine milestone awards since the company launched in January 2013.
    Full story
  • N-of-One and Appistry Announce Partnership

    Feb 18, 2014, 13:00 PM by Michael Croft
    Boston Business Journal | N-of-One and Appistry have partnered to more easily bring N-of-One's diagnostics plans to health care organizations.
    Full story
  • GenapSys Inc. Opens Early Access Registration for the World's First Pure Electronic DNA Sequencer - the GENIUS 110™

    Feb 18, 2014, 00:00 AM by Michael Croft
    REDWOOD CITY, CA - GenapSys Inc. unveiled the GENIUS 110™ Next Generation DNA Sequencing System at the AGBT (Advances in Genome Biology & Technology) sequencing technology conclave held on Marco Island, FL.  Dr. Hesaam Esfandyarpour, founder and ceo, presented the revolutionary GENIUS DNA sequencer with a footprint no bigger than an Apple® iPad® and that promises to make DNA sequencing widely available to individual researchers and diagnostic laboratories for the first time.
    Full story
  • Rhenovia Pharma secures Series B funding

    Feb 18, 2014, 00:00 AM by Michael Croft
    MULHOUSE, FRANCE, CAMBRIDGE, MA - Rhenovia Pharma, a biotechnology company specialized in the application of biosimulation to the research and development of new medicinal products, today announces that it has raised EUR 540,000 (USD 738,000) from its historical shareholders in a second round of funding. 
    Full story
  • Patient Stratification in Clinical Trials Emerges as Theme at MMTC

    Feb 17, 2014, 14:00 PM by Michael Croft
    Bio-IT World | The 21st annual Molecular Medicine Tri-Conference in San Francisco featured some intense scrutiny of one area where genetic knowledge is ready to make an impact today: better defining the best patient populations for treatment during clinical trials.
    Full story
  • eClipse Enterprise Solutions becomes ISO9001: 2008 certified continuing its commitment to high-quality service delivery

    Feb 17, 2014, 00:00 AM by Michael Croft
    EXETER, NH - eClipse Enterprise Solutions becomes ISO9001: 2008 certified
    Full story
  • Illumina Launches Genomics Accelerator

    Feb 13, 2014, 09:00 AM by Michael Croft
    Xconomy | Illumina is creating a genomics-focused accelerator at its Mission Bay R&D facility under construction in San Francisco.
    Full story
  • «
  • 411 (current)
  • 412
  • 413
  • 414
  • 415
  • 416
  • 417
  • 418
  • 419
  • 420
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy